Eli Lilly's (LLY) sofetabart mipitecan receives US FDA's Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer
Eli Lilly's receipt of Breakthrough Therapy designation for its drug sofetabart mipitecan is a significant milestone, indicating accelerated development and potential market exclusivity in treating platinum-resistant ovarian cancer.
Around 2 borrowers are looking to sell new US investment-grade notes on Tuesday, according too Bloomberg's daily survey
Amazon (AMZN) CEO Jassy says seeing some sellers passing along tariffs and others absorbing it; in the next couple of years, could see them having fewer people than they had before - CNBC
Eli Lilly's (LLY) sofetabart mipitecan receives US FDA's Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer
EU set to approve Universal Music's (UMG) downtown buy
NBP said to to approve plan to increase gold holdings to 700 tonnes
Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.
This designation often leads to increased investor confidence and can drive the stock's performance positively, particularly in the biotech sector, which is sensitive to regulatory news. Watch for market reactions around competitor products and overall sentiment in health care stocks.
Related headlines
- Burry adds to his positions in Zoetis (ZTS) and Lululemon (LULU); sold entire position in Flutter (FLUT)1 day ago
- Daily US Equity Opening News: ORCL gains on earnings and FY guidance beat; ADBE weighed by slight Q4 revenue miss; SMR downgraded2 days ago
- Newsquawk Weekly US Earnings Estimates: 14-18th September 2026: LEN the only earning all week1 day ago
- Corning (GLW) files for a USD 2bln common stock offering of up to USD 2.0bln1 day ago
- Google (GOOGL) just completed its USD 1.5bln-plus deal for AI startup Mechanize, reports Business Insider1 day ago
- Estee Lauder (EL) reportedly advances against Walmart (WMT) over knockoffs, according to Bloomberg Law2 days ago
- Paypal's (PYPL) new chief executive, Enrique Lores, is mapping out his plans for going it alone rather than selling the company for more than USD 50bln, reports WSJ2 days ago
- US EQUITY OPEN: US indices reverse initial CPI losses2 days ago
- Fox's Gasparino says "Paramount’s (PSKY) CEO has "tricks up his sleeve" to get his Warner (WBD) acquisition cleared in California"2 days ago
- Chevron (CVX) CEO says early buffers in the oil market have played out and that the price risk from the Iran war is now higher2 days ago
- Kroger (KR) executive says food inflation in Q2 was moderately higher than in Q12 days ago
- US PREMARKET MOVERS: ORCL, ADBE, ACVA, KR, RH, CELH, GME, NVO, SMR2 days ago
- US BROKER MOVES: IP upgraded at BofA; NVO downgraded at Morgan Stanley2 days ago
- Kroger (KR) Q2 2026 (USD): Adj. EPS 1.09 (exp. 1.06), revenue 34.6bln (exp. 34.6bln). Cuts SSS outlook 2 days ago
- EU officials have questioned cloud providers for more information ahead of a key deadline in their argument with Broadcom (AVGO) over the licensing overhaul for VMware, Bloomberg reports2 days ago
- TikTok has reportedly rejected advertisements from Meta (META) that call on the Co. and other tech platforms to join Meta in settling with US state AGs in a children's safety lawsuit, Axios reports2 days ago
- Tesla (TSLA) China launches new Model Y Performance AWD, priced at CNY 369k2 days ago
- Situational Awareness builds relationships with new brokers as it attempts rebound, reports FT; is rebuilding large trading positions in stocks such as AMD (AMD), Intel (INTC), SK Hynix (SHY), Sandisk (SNDK) and Coreweave (CRWV)2 days ago
- FanDuel (FLTR) and other sports betting operators are market making on Kalshi, reports Barrons2 days ago
- Newsquawk US Market Wrap: Markets chop, and yields flatten after hot core CPI boosts Fed rate hike bets1 day ago
The whole workspace, free to try.
Try it free